Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

FREE BLOG Theranos may have failed, but it radically changed the lab sector

Theranos posited the idea that you could do a bunch of very low cost tests from pharmacies. Whilst it has so far failed to deliver on this, that threat has changed the sector. There are now plenty more newbies who want to do the same, such as Brainshake, whose CEO we interview here.
September 13, 2016

Krishna-KIMS to IPO

The Krishna Institute of Medical Sciences (KIMS), which provides super-specialty care in Hyderabad and the nearby region of Andhra Pradesh, wants to become the latest Indian group to IPO. KIMS has reportedly hired three investment banks to manage the sale and will release its prospectus at the end of the year.
September 12, 2016

Sweden contemplates a 10% private profits cap on welfare

Political risk for public-private welfare companies is resurfacing in Sweden. A parliamentary investigation has launched that could potentially limit return on equity plus net debt in the sector at 10% adjusted for inflation. Listed healthcare groups Capio, Attendo and Humana's share price dropped at 4-5% on the news.
September 12, 2016

European listed care groups: A financial review and comparison

First half 2016 results for the major care home groups point towards solid 5-6% organic sales growth from Orpea and Korian with the latter gradually recovering from the crisis which saw the replacement of CEO Yann Coleou at the turn of 2015. Recently listed Nordic groups Attendo and Humana are benefitting from strong demand for new nursing home beds from public payors and expansion in Finland. But Swedish proposals to limit the return on public-private care services to 8% of return on equity plus net debt (before inflation) pushed shares down. Meanwhile, Middle Eastern investors have bought in to Italian operator KOS.
September 12, 2016

No let up for Russian imagers, says chairman of country’s largest player

Times are still hard for Russian imaging groups despite the rouble stabilising after two years of dramatic decline, says Arkadi Stolpner, the chairman of the country's largest player. Margins should be around 15% this year, he claims, but his business, the Diagnostic Treatment Centre (DTC), will still expand through 12 nuclear medicine centres over the next three to four years.
September 12, 2016

No let up for Russian imagers, says CEO of Diagnostic Treatment Centre

Times are still hard for Russian imaging groups despite the rouble stabilising after two years of dramatic decline, says Arkadi Stolpner, the CEO of the largest player. Margins should be around 15% this year, he claims, but his business, the Diagnostic Treatment Centre (DTC), will still expand through 12 nuclear medicine centres over the next three to four years.
September 9, 2016

Interview: Teemu Suna, CEO, Finnish biomedical company Brainshake

Brainshake is a Finnish biomedical company that claims to revolutionise blood testing. It tests for over 200 biomarkers opening a far broader window into the health state of an individual than existing blood tests. And despite beginning commercial operations just three years ago, it already has global ambitions and claims to be highly profitable – enough to secure €5m of primarily non-equity funding. We interviewed its CEO Teemu Suna.
September 9, 2016

International hospital groups: Financial review and comparison

How is the international hospital sector faring? We look at the results to March or June from the four main players: Australian operator Ramsay Health Care and the Big Three South Africans - Netcare, Mediclinic and Lifehealth. What do they say about their health and the globalisation of the private hospital sector. We talk to analysts.
September 8, 2016

FREE BLOG Shock therapy for Nigerian healthcare

Private investment in Nigerian healthcare has recently on a bit of a high. There were few investors or groups with an emerging market presence that were not linked with the market. But, with its economy relapsing into self-harm, we weren’t sure what to expect from our investigation.
September 8, 2016
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us